PHASE-II STUDY OF LONIDAMINE IN CANCER-PATIENTS

被引:10
作者
BAND, PR
DESCHAMPS, M
BESNER, JG
LECLAIRE, R
GERVAIS, P
DESANCTIS, A
机构
[1] ANGELINI FRANCESCO RES INST,ROME,ITALY
[2] UNIV MONTREAL,FAC NURSING,MONTREAL H3C 3J7,QUEBEC,CANADA
[3] UNIV MONTREAL,FAC PHARM,MONTREAL H3C 3J7,QUEBEC,CANADA
关键词
D O I
10.1159/000225889
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:66 / 68
页数:3
相关论文
共 5 条
[1]   PHASE-I TOXICOLOGIC STUDY OF LONIDAMINE IN CANCER-PATIENTS [J].
BAND, PR ;
DESCHAMPS, M ;
BESNER, JG ;
LECLAIRE, R ;
GERVAIS, P ;
DESANCTIS, A .
ONCOLOGY, 1984, 41 :56-59
[2]   PHARMACOKINETICS OF LONIDAMINE AFTER ORAL-ADMINISTRATION IN CANCER-PATIENTS [J].
BESNER, JG ;
LECLAIRE, R ;
BAND, PR ;
DESCHAMPS, M ;
DESANCTIS, AJ ;
CATANESE, B .
ONCOLOGY, 1984, 41 :48-52
[3]  
FLORIDI A, 1981, J NATL CANCER I, V66, P497
[4]  
FLORIDI A, 1981, CANCER RES, V41, P4661
[5]   BASIC AND APPLIED-RESEARCH IN THE STUDY OF INDAZOLE CARBOXYLIC-ACIDS [J].
SILVESTRINI, B .
CHEMOTHERAPY, 1981, 27 :9-20